HYPERFINE INC (HYPR) Stock News

Hyperfine, Inc. to Participate in Upcoming Jefferies Global Healthcare Conference

Hyperfine Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)

Hyperfine, Inc. (HYPR) Reports Q1 Loss, Lags Revenue Estimates

Hyperfine (HYPR) delivered earnings and revenue surprises of 0% and 27.07%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Hyperfine, Inc. Reports First Quarter 2025 Financial Results

GUILFORD, Conn., May 13, 2025 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain...

Hyperfine, Inc. Reports First Quarter 2025 Financial Results

Earnings Scheduled For May 13, 2025

Mentions: ICMB IRIX KLC ONON ...

TransMedics (TMDX) Tops Q1 Earnings and Revenue Estimates

TransMedics (TMDX) delivered earnings and revenue surprises of 141.38% and 16.17%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Mentions: TMDX

Hyperfine, Inc. to Announce First Quarter 2025 Financial Results on May 13, 2025

Hyperfine Enrolls Initial Patients in NEURO PMR Study to Evaluate Use of AI-Powered Portable MRI in Neurology Offices

Hyperfine, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

GUILFORD, Conn., March 17, 2025 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain...

Hyperfine, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

Hyperfine and NVIDIA Collaborate to Revolutionize Neuroimaging with AI-Powered Innovation

Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025

Hyperfine Announces $6.0 Million Registered Direct Offering

Hyperfine Reports on Growing Evidence for the Use of Swoop® System Images in Stroke Diagnosis Presented at the 2025 International Stroke Conference

Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern Markets

Hyperfine Announces Extensive Clinical Study Coverage at RSNA 2024, Showcasing the Body of Evidence Supporting the Use of the Swoop® System Across Different Sites of Care

Hyperfine Announces Strategic Leadership Additions to Drive Growth in Key Business Verticals

Hyperfine Swoop® Portable MR Brain Imaging System Meets New Standards Recently Issued by CMS-Approved Accrediting Body

Hyperfine Announces Ten Abstracts at RSNA, Highlighting the Expanding Utility and Potential of Portable MR Brain Imaging in Diverse Clinical and Research Settings

Hyperfine, Inc. to Participate in Upcoming Investor Conferences